May 26, 2026 08:00AM
May 26, 2026 08:00AM
May 14, 2026 04:30PM
May 13, 2026 08:00AM
May 1, 2026 09:36AM
May 1, 2026 07:01AM
May 1, 2026 07:00AM Esperion to be Acquired by ARCHIMED
Apr 23, 2026 08:00AM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:00PM
Apr 2, 2026 04:00PM
Mar 31, 2026 08:00AM
Mar 30, 2026 08:05AM Esperion presents stroke reduction data for NEXLETOL at cardiology conference
Mar 30, 2026 08:00AM
Mar 17, 2026 08:00AM
Mar 16, 2026 06:31AM
Mar 16, 2026 06:30AM
Mar 13, 2026 05:40AM
Mar 10, 2026 12:17PM
Mar 10, 2026 06:00AM Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 3, 2026 06:00AM
Mar 3, 2026 06:00AM
Feb 24, 2026 08:00AM
Feb 18, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 17, 2026 08:00AM Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
Feb 17, 2026 08:00AM
Feb 11, 2026 04:30PM
Jan 11, 2026 06:00PM
Jan 5, 2026 08:00AM
Dec 19, 2025 08:00AM
Jul 24, 2025 12:48PM
Jul 1, 2025 08:07AM Esperion Therapeutics (ESPR) Appoints Craig Thompson to its Board
Jul 1, 2025 08:06AM
May 8, 2025 06:30AM
May 8, 2025 06:30AM
Mar 4, 2025 06:00AM
Dec 18, 2024 07:01AM
Dec 18, 2024 07:00AM
Jan 4, 2022 08:00AM Esperion Appoints Benjamin O. Looker as General Counsel
Jan 4, 2022 08:00AM
May 5, 2021 09:30AM
Apr 26, 2021 04:27PM
Apr 26, 2021 04:07PM
Apr 26, 2021 04:07PM
Feb 14, 2020 05:40AM
Jun 26, 2019 04:12PM Esperion Therapeutics (ESPR) and Oberland Capital Announce $200 Million Funding Agreement
Jun 26, 2019 04:10PM

1,157,750 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All